{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:23:31Z","timestamp":1790054611218,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007557","name":"California Institute of Regenerative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007557","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.bbrc.2014.08.152","type":"journal-article","created":{"date-parts":[[2014,9,6]],"date-time":"2014-09-06T12:56:35Z","timestamp":1410008195000},"page":"753-759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Inhibition of DNA methylation enhances HLA-G expression in human mesenchymal stem cells"],"prefix":"10.1016","volume":"452","author":[{"given":"Takele","family":"Teklemariam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhamini","family":"Purandare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longmei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil M.","family":"Hantash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.08.152_b0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2014.08.152_b0010","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1091\/mbc.e02-02-0105","article-title":"Human adipose tissue is a source of multipotent stem cells","volume":"13","author":"Zuk","year":"2002","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbrc.2014.08.152_b0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/107632701300062859","article-title":"Multilineage cells from human adipose tissue: implications for cell-based therapies","volume":"7","author":"Zuk","year":"2001","journal-title":"Tissue Eng."},{"key":"10.1016\/j.bbrc.2014.08.152_b0020","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1242\/jcs.02932","article-title":"Mesenchymal stem cells reside in virtually all post-natal organs and tissues","volume":"119","author":"da Silva Meirelles","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbrc.2014.08.152_b0025","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1182\/blood-2003-11-3909","article-title":"Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation","volume":"103","author":"Meisel","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2014.08.152_b0030","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","article-title":"Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation","volume":"107","author":"Spaggiari","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2014.08.152_b0035","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12185-011-0989-2","article-title":"Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 study","volume":"95","author":"Herrmann","year":"2012","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bbrc.2014.08.152_b0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","article-title":"Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study","volume":"11","author":"Connick","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbrc.2014.08.152_b0045","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.clineuro.2012.02.003","article-title":"Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients","volume":"114","author":"Karamouzian","year":"2012","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.bbrc.2014.08.152_b0050","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1097\/TP.0b013e3181a2a4b3","article-title":"HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells","volume":"87","author":"Selmani","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.bbrc.2014.08.152_b0055","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2014.08.152_b0060","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.2326636","article-title":"A class I antigen, HLA-G, expressed in human trophoblasts","volume":"248","author":"Kovats","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2014.08.152_b0065","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.humimm.2003.08.346","article-title":"Expression of HLA-G in human cornea, an immune-privileged tissue","volume":"64","author":"Le Discorde","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.bbrc.2014.08.152_b0070","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1158\/0008-5472.CAN-05-0097","article-title":"HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?","volume":"65","author":"Rouas-Freiss","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2014.08.152_b0075","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1093\/brain\/awh609","article-title":"Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity","volume":"128","author":"Wiendl","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.bbrc.2014.08.152_b0080","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.4049\/jimmunol.166.8.5018","article-title":"HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis","volume":"166","author":"Riteau","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2014.08.152_b0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0165-0378(99)00034-0","article-title":"HLA-G inhibits the allogeneic proliferative response","volume":"43","author":"Riteau","year":"1999","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.bbrc.2014.08.152_b0090","doi-asserted-by":"crossref","first-page":"11520","DOI":"10.1073\/pnas.94.21.11520","article-title":"Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis","volume":"94","author":"Rouas-Freiss","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.08.152_b0095","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.0000015075.89984.46","article-title":"Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection","volume":"105","author":"Lila","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2014.08.152_b0100","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0065-2776(03)81006-4","article-title":"HLA-G molecules: from maternal-fetal tolerance to tissue acceptance","volume":"81","author":"Carosella","year":"2003","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.bbrc.2014.08.152_b0105","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s00018-002-8521-8","article-title":"HLA-G protein processing and transport to the cell surface","volume":"59","author":"Moreau","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2014.08.152_b0110","doi-asserted-by":"crossref","first-page":"201371","DOI":"10.4061\/2011\/201371","article-title":"Epigenetic regulation of mesenchymal stem cells: a focus on osteogenic and adipogenic differentiation","volume":"2011","author":"Teven","year":"2011","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.bbrc.2014.08.152_b0115","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.leukres.2008.08.003","article-title":"Demethylating agent 5-aza-2\u2032-deoxycytidine activates HLA-G expression in human leukemia cell lines","volume":"33","author":"Polakova","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrc.2014.08.152_b0120","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1073\/pnas.0337539100","article-title":"HLA-G gene repression is reversed by demethylation","volume":"100","author":"Moreau","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.08.152_b0125","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1002\/art.10696","article-title":"Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells","volume":"46","author":"Jones","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbrc.2014.08.152_b0130","doi-asserted-by":"crossref","first-page":"e19988","DOI":"10.1371\/journal.pone.0019988","article-title":"Long-lasting inhibitory effects of fetal liver mesenchymal stem cells on T-lymphocyte proliferation","volume":"6","author":"Giuliani","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbrc.2014.08.152_b0135","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/14653249.2011.613926","article-title":"Enhancement of the immunosuppressive effect of human adipose tissue-derived mesenchymal stromal cells through HLA-G1 expression","volume":"14","author":"Yang","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbrc.2014.08.152_b0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2217\/rme.13.82","article-title":"Temporal HLA profiling and immunomodulatory effects of human adult bone marrow- and adipose-derived mesenchymal stem cells","volume":"9","author":"Purandare","year":"2014","journal-title":"Regen. Med."},{"key":"10.1016\/j.bbrc.2014.08.152_b0145","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","article-title":"HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells","volume":"31","author":"Le Blanc","year":"2003","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bbrc.2014.08.152_b0150","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.humimm.2012.06.007","article-title":"Full-length HLA-G1 and truncated HLA-G3 differentially increase HLA-E surface localization","volume":"73","author":"Teklemariam","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.bbrc.2014.08.152_b0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbrc.2014.08.152_b0160","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1073\/pnas.0811586106","article-title":"Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions","volume":"106","author":"Pan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2014.08.152_b0165","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2014.08.152_b0170","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.tp.0000267918.07906.08","article-title":"Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G","volume":"84","author":"Nasef","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.bbrc.2014.08.152_b0175","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2014.08.152_b0180","first-page":"1017","article-title":"Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells","volume":"90","author":"Gotherstrom","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bbrc.2014.08.152_b0185","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1634\/stemcells.2006-0071","article-title":"Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma","volume":"24","author":"Chang","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbrc.2014.08.152_b0190","doi-asserted-by":"crossref","first-page":"e10192","DOI":"10.1371\/journal.pone.0010192","article-title":"Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells","volume":"5","author":"Suarez-Alvarez","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbrc.2014.08.152_b0195","first-page":"631","article-title":"The role of mammalian DNA methyltransferases in the regulation of gene expression","volume":"10","author":"Turek-Plewa","year":"2005","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bbrc.2014.08.152_b0200","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1038\/sj.onc.1205699","article-title":"5-Azacytidine and 5-aza-2\u2032-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy","volume":"21","author":"Christman","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2014.08.152_b0205","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/14653240802105299","article-title":"A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells","volume":"10","author":"Rizzo","year":"2008","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbrc.2014.08.152_b0210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/157488810790442859","article-title":"Epigenetic remodeling of chromatin architecture: exploring tumor differentiation therapies in mesenchymal stem cells and sarcomas","volume":"5","author":"Siddiqi","year":"2010","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrc.2014.08.152_b0215","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.diff.2010.09.183","article-title":"Epigenetic modifiers influence lineage commitment of human bone marrow stromal cells: differential effects of 5-aza-deoxycytidine and trichostatin A","volume":"81","author":"El-Serafi","year":"2011","journal-title":"Differentiation"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14015964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14015964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:10:15Z","timestamp":1757761815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14015964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0006291X14015964"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.08.152","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of DNA methylation enhances HLA-G expression in human mesenchymal stem cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.08.152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}